Current Eligibility Criteria

Last updated: March 22, 2021

• Super-Sites and Pop-up Clinics
• Medical Clinics and Pharmacies

Super-Sites and Pop-up Clinics

• Information on Super-site and Pop-up Clinic locations

Individuals:

• 65 years of age and older (NEW: expanded from aged 67 or older)
• 45 years of age and older for First Nation people (NEW: expanded from aged 47 or older)

When it’s your turn, don’t forget to bring a signed consent form and other items from the checklist of things to bring with you (pdf) to your appointment.

Individuals working in the following settings, who may or may not have direct contact with patients or residents, are eligible:

• work in acute care facilities (NEW: includes all people working in these settings, expanded from only those who have direct contact with patients);
• assigned to a COVID-19 immunization clinic, designated COVID-19 testing site, or designated COVID-19 alternative isolation accommodations facility;
• work in congregate living facilities (list of congregate living facilities);
• work in licensed personal care homes.

Healthcare workers, who may or may not provide direct patient care, who work in outpatient healthcare settings including:

• clinics, diagnostic imaging, laboratories, emergency response services and patient transport, blood donor centres, surgical centres, elderly day programs and home based care.

Eligibility also includes these community services workers:

• staff employed in congregate group care settings who provide direct care to individuals in homeless shelters, family violence shelters, emergency placement shelters and second stage housing; or
• staff employed in congregate group care settings who provide direct care to individuals in Community Living disABILITY Services or the child and family services sector. Manitoba Families will identify eligible staff and contact them directly to schedule appointments.

Medical Clinics and Pharmacies

The AstraZeneca/COVISHIELD vaccine doses will primarily be used to provide COVID-19 vaccines in doctors’ offices and pharmacies. Manitoba public health officials have developed guidance for the use of the AstraZeneca/Covishield vaccine. This information is being shared with providers and posted online to guide how appointments are booked once the vaccine is available in Manitoba clinics and pharmacies.

Eligibility Criteria

As part of the piloted roll-out of the AstraZeneca/Covishield, Manitobans aged 50 to 64 years (First Nations people aged 30 to 64) with a high-risk condition will be the first group eligible to receive the AstraZeneca/Covishield COVID-19 vaccine. These individuals are at increased risk of experiencing serious illness requiring hospitalization or death related to COVID-19.

Anyone who is ALREADY eligible for the Pfizer/Moderna COVID-19 vaccine (such as health care workers) and is aged 18 to 64 is also eligible to receive AstraZeneca/ Covishield COVID-19 vaccine.

However, anyone who has already received a dose of the Pfizer or Moderna mRNA vaccines must use the same product for their second dose, and should not receive the AstraZeneca/Covishield vaccine.

People with high-risk conditions (as determined by their doctor or pharmacist) will be prioritized, with those who have a condition in Priority List 1 being offered immunization before those with a condition in Priority List 2.

Priority List 1:

• Individuals with the following chronic health conditions:
  • end stage renal disease undergoing hemodialysis OR peritoneal dialysis
  • cirrhosis due to any cause OR portal hypertension
  • heart failure (class III/IV ), ventricular assist device OR adult congenital heart disease stage C and D
  • severe COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease OR cystic fibrosis
  • history of cerebral vascular accident with residual deficits
  • malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
  • malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
  • severe obesity (BMI ≥ 40)
  • receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
  • solid organ or hematopoietic stem cell transplant (candidate or recipient)
  • trisomy 21 (Down syndrome)
  • asplenia or hyposplenism (including sickle cell disease)
• Individuals receiving home care ≥ 4 times/week OR receive 24/7 support from Community Living Disability Services.
• Pregnant individuals (18 to ≤ 64 years of age) with one of: aged ≥ 35 years, BMI ≥ 30, pre-existing diabetes, pre-existing hypertension, cardiac or pulmonary disease.

Priority List 2:

• Individuals with the following chronic health conditions:
  • Chronic cardiovascular disease including heart failure (class I/II), coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
  • chronic liver disease
  • chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson’s disease, multiple sclerosis, ALS OR dementia (including Alzheimer’s disease)
  • chronic pulmonary disease including COPD OR severe and/or uncontrolled asthma
  • chronic renal disease
  • HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
  • severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
  • type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
  • active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
  • receiving immunosuppressing therapy
• Individuals receiving homecare ≤ 3 times/week OR any level of Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
• Household contacts of individuals with Priority 1 chronic health conditions OR designated support person(s) for personal care home residents (in the authorized age category).